Combination of HPV16 E6, E7, MYC and activated HRAS were used as additional oncogenes as we previously had shown that these oncogenes were sufficient to convert several normal human epithelial cells into tumorigenic cells [12].Thus it is likely this combination can convert any non-tumorigenic ovarian cancer cell lines in mice into tumorigenic. This evidence concerns the gene HRAS and ovarian carcinoma.